Sponsor Pipeline

Antidote Therapeutics, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07215923 A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers Thromboangiitis Obliterans (Buerger's Disease) Recruiting
Get alerts when Antidote Therapeutics, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free